Hims & Hers Health (NYSE:HIMS) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $0.08 by 275 percent. This is a 255.56 percent decrease over earnings of $0.09 per share from the same period last year. The company reported quarterly sales of $890.373 million which missed the analyst consensus estimate of $892.888 million by 0.28 percent. This is a 48.65 percent increase over sales of $598.976 million the same period last year.